Prevention of chemotherapy-induced peripheral neuropathy: a review of recent findings
EY Ibrahim, BE Ehrlich - Critical reviews in oncology/hematology, 2020 - Elsevier
Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect of chemotherapy
that is frequently experienced by patients receiving treatment for cancer. CIPN is caused by …
that is frequently experienced by patients receiving treatment for cancer. CIPN is caused by …
[HTML][HTML] The MAMs structure and its role in cell death
N Wang, C Wang, H Zhao, Y He, B Lan, L Sun, Y Gao - Cells, 2021 - mdpi.com
The maintenance of cellular homeostasis involves the participation of multiple organelles.
These organelles are associated in space and time, and either cooperate or antagonize …
These organelles are associated in space and time, and either cooperate or antagonize …
Balancing ER-mitochondrial Ca2+ fluxes in health and disease
J Loncke, A Kaasik, I Bezprozvanny, JB Parys… - Trends in cell …, 2021 - cell.com
Organelles cooperate with each other to control cellular homeostasis and cell functions by
forming close connections through membrane contact sites. Important contacts are present …
forming close connections through membrane contact sites. Important contacts are present …
New Insights in the IP3 Receptor and Its Regulation
JB Parys, T Vervliet - Calcium signaling, 2020 - Springer
Abstract The inositol 1, 4, 5-trisphosphate (IP 3) receptor (IP 3 R) is a Ca 2+-release channel
mainly located in the endoplasmic reticulum (ER). Three IP 3 R isoforms are responsible for …
mainly located in the endoplasmic reticulum (ER). Three IP 3 R isoforms are responsible for …
Calcium sensors in neuronal function and dysfunction
RD Burgoyne, N Helassa… - Cold Spring Harbor …, 2019 - cshperspectives.cshlp.org
Calcium signaling in neurons as in other cell types can lead to varied changes in cellular
function. Neuronal Ca2+ signaling processes have also become adapted to modulate the …
function. Neuronal Ca2+ signaling processes have also become adapted to modulate the …
Calpain as a therapeutic target in cancer
I Shapovalov, D Harper, PA Greer - Expert Opinion on Therapeutic …, 2022 - Taylor & Francis
ABSTRACT Introduction Calpain-1 and calpain-2 are prototypical classical isoforms of the
calpain family of calcium-activated cysteine proteases. Their substrate proteins participate in …
calpain family of calcium-activated cysteine proteases. Their substrate proteins participate in …
[HTML][HTML] Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis
Y Lv, WT Tang, YQ Xu, WJ Chang… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Aim: Colorectal cancer (CRC) is the leading cause of cancer associated death worldwide
and immune checkpoint blockade therapy only benefit a small set of CRC patients. Tumor …
and immune checkpoint blockade therapy only benefit a small set of CRC patients. Tumor …
[HTML][HTML] Cav2. 3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease
J Benkert, S Hess, S Roy, D Beccano-Kelly… - Nature …, 2019 - nature.com
Degeneration of dopaminergic neurons in the substantia nigra causes the motor symptoms
of Parkinson's disease. The mechanisms underlying this age-dependent and region …
of Parkinson's disease. The mechanisms underlying this age-dependent and region …
[HTML][HTML] Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson's iPSC-dopamine neurons
DA Beccano-Kelly, M Cherubini, Y Mousba… - Iscience, 2023 - cell.com
Parkinson's disease (PD) is characterized by a progressive deterioration of motor and
cognitive functions. Although death of dopamine neurons is the hallmark pathology of PD …
cognitive functions. Although death of dopamine neurons is the hallmark pathology of PD …
Mechanistic insights into the pathogenesis of microtubule‐targeting agent‐induced peripheral neuropathy from pharmacogenetic and functional studies
KC Chua, N El‐Haj, J Priotti… - Basic & clinical …, 2022 - Wiley Online Library
Chemotherapy‐induced peripheral neuropathy (CIPN) is a common dose‐limiting toxicity
that affects 30%–40% of patients undergoing cancer treatment. Although multiple …
that affects 30%–40% of patients undergoing cancer treatment. Although multiple …